Literature DB >> 16798837

Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients.

M Berretta, A Lleshi, F Di Benedetto, A Bearz, M Spina, U Tirelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798837     DOI: 10.1093/annonc/mdj140

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma.

Authors:  Nicolas Williet; Olivier Dubreuil; Tarek Boussaha; Isabelle Trouilloud; Bruno Landi; Martin Housset; Muriel Botti; Philippe Rougier; Jacques Belghiti; Julien Taieb
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

2.  Metachronous pulmonary and adrenal metastases after liver transplantation for hepatocarcinoma.

Authors:  Shan-Wen Chen; Shuo Wang; Bo Wang; Wei-Dong Li; Sheng Yan; Li-Ping Xie
Journal:  World J Surg Oncol       Date:  2011-11-28       Impact factor: 2.754

3.  Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments.

Authors:  Sheng-Li He; Jie Shen; Xian-Jun Sun; Xiao-Juan Zhu; Lu-Ming Liu; Jing-Cheng Dong
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.